Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent (177)Lu-Labeled Radiohapten. Vaughn BA, Lee SG, Vargas DB, Seo S, et al. J Nucl Med 2024;65:1611-1618.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vaughn BA, Lee SG, Vargas DB, Seo S, et al. Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent (177)Lu-Labeled Radiohapten. J Nucl Med 2024;65:1611-1618.
PMID: 39168519